BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17386963)

  • 1. Characterization of recombinant foot-and-mouth disease virus pentamer-like structures expressed by baculovirus and their use as diagnostic antigens in a blocking ELISA.
    Oem JK; Park JH; Lee KN; Kim YJ; Kye SJ; Park JY; Song HJ
    Vaccine; 2007 May; 25(20):4112-21. PubMed ID: 17386963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant protein-based ELISA for detecting antibodies to foot-and-mouth disease virus serotype Asia 1.
    Ko YJ; Jeoung HY; Lee HS; Chang BS; Hong SM; Heo EJ; Lee KN; Joo HD; Kim SM; Park JH; Kweon CH
    J Virol Methods; 2009 Jul; 159(1):112-8. PubMed ID: 19442854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay.
    Ko YJ; Choi KS; Nah JJ; Paton DJ; Oem JK; Wilsden G; Kang SY; Jo NI; Lee JH; Kim JH; Lee HW; Park JM
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):922-9. PubMed ID: 16085909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody.
    Sørensen KJ; de Stricker K; Dyrting KC; Grazioli S; Haas B
    Arch Virol; 2005 Apr; 150(4):805-14. PubMed ID: 15645377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a major antibody binding epitope in the non-structural protein 3D of foot-and-mouth disease virus in cattle and the development of a monoclonal antibody with diagnostic applications.
    Yang M; Clavijo A; Li M; Hole K; Holland H; Wang H; Deng MY
    J Immunol Methods; 2007 Apr; 321(1-2):174-81. PubMed ID: 17320098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals.
    Lu Z; Cao Y; Guo J; Qi S; Li D; Zhang Q; Ma J; Chang H; Liu Z; Liu X; Xie Q
    Vet Microbiol; 2007 Nov; 125(1-2):157-69. PubMed ID: 17601688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site.
    Rémond M; Da Costa B; Riffault S; Parida S; Breard E; Lebreton F; Zientara S; Delmas B
    Vaccine; 2009 Jan; 27(1):93-8. PubMed ID: 18983883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a liquid-phase blocking ELISA based on foot-and-mouth disease virus empty capsid antigen for seromonitoring vaccinated animals.
    Basagoudanavar SH; Hosamani M; Tamil Selvan RP; Sreenivasa BP; Saravanan P; Chandrasekhar Sagar BK; Venkataramanan R
    Arch Virol; 2013 May; 158(5):993-1001. PubMed ID: 23242775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype-independent detection of foot-and-mouth disease virus.
    Muller JD; McEachern JA; Bossart KN; Hansson E; Yu M; Clavijo A; Hammond JM; Wang LF
    J Virol Methods; 2008 Jul; 151(1):146-53. PubMed ID: 18440078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
    Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
    Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of monoclonal antibodies against VP2 protein of Asia I type foot-and-mouth disease virus and establishment of a competitive ELISA for the detection of antibodies].
    Xiang M; Zhang K; Lu S; Cai L; Luo Y; Zhang J; He H; Wang Q; Wu B
    Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1664-9. PubMed ID: 19160854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of indirect ELISA diagnose based on the VP1 structural protein of foot-and-mouth disease virus (FMDV) in pigs].
    Wang GH; Du JZ; Cong GZ; Shao JJ; Lin T; Xue HW; Chang HY; Xie QG
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):961-6. PubMed ID: 18051883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
    Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
    Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus.
    Yang M; Clavijo A; Suarez-Banmann R; Avalo R
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):126-34. PubMed ID: 17109972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of virus-like particles from O-type foot-and-mouth disease virus in insect cells using codon-optimized synthetic genes.
    Cao Y; Sun P; Fu Y; Bai X; Tian F; Liu X; Lu Z; Liu Z
    Biotechnol Lett; 2010 Sep; 32(9):1223-9. PubMed ID: 20464450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
    Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
    Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
    J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.